Phase
Condition
Sexually Transmitted Diseases (Stds)
Rash
Gynecological Infections
Treatment
N/AClinical Study ID
Ages 18-60 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Persons with confirmed early symptomatic syphilis (primary or secondary) or high-titerlatent syphilis
A rapid plasma reagin (RPR) test was positive, with a titer were 1:4 or higher. Inaddition, Treponema pallidum particle agglutination assay and/or fluorescenttreponemal antibody absorption test were reactive.
Exclusion
Exclusion Criteria:
1.Patients who were pregnancy, known allergy to penicillin, use of antibiotics activeagainst syphilis during the preceding six months for symptomatic cases or during thepreceding two years for asymptomatic cases, and concurrent illnesses requiring treatmentwith antibiotics effective against syphilis. 2. if RPR titers were found to be 1:4 or lessor the T. pallidum particle agglutination test was nonreactive, participants wereretrospectively excluded from the trial unless primary syphilis was confirmed by thefinding of T. pallidum in ulcer exudates on direct immunofluorescence
Study Design
Connect with a study center
Department of Dermatology and Venereology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Beijing,
ChinaActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.